ANKK1 Gene: Ankyrin Repeat and Kinase Domain Containing 1

Genetic insights into ANKK1, a key gene in dopamine receptor signaling and neuropsychiatric disorders.

Gene Information Card

Symbol ANKK1
Full Name Ankyrin repeat and kinase domain containing 1
Gene Type Protein coding
Chromosomal Location 11q23.2
NCBI Gene ID 255239 ncbi.nlm.nih.gov/gene/255239
Ensembl ID ENSG00000170214
UniProt ID Q8NFH3
OMIM ID 608774
HGNC ID 21016
Aliases PKK2, RP1-278O11.2

Description

The ANKK1 gene (ankyrin repeat and kinase domain containing 1) encodes a protein with ankyrin repeats and a serine/threonine kinase domain. It is located adjacent to the dopamine receptor D2 (DRD2) gene on chromosome 11q23.2. The ANKK1 protein is involved in signal transduction pathways, and its Taq1A polymorphism (rs1800497) has been extensively studied in relation to dopamine signaling, addiction, and neuropsychiatric disorders. The gene is expressed in various brain regions and peripheral tissues.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Alcohol dependence The Taq1A polymorphism (rs1800497) in ANKK1 is associated with altered DRD2 expression and dopamine receptor density, influencing reward pathways and addiction risk. Multiple case-control and meta-analysis studies (e.g., NCBI PubMed, ClinVar).
Tourette syndrome ANKK1 variants may modulate dopaminergic neurotransmission, contributing to tic disorders. Genetic association studies (OMIM #608774).
Schizophrenia Polymorphisms in ANKK1 have been linked to dopamine dysregulation and antipsychotic response variability. ClinVar and GWAS catalog entries.
Bipolar disorder ANKK1 variants may affect mood regulation through dopamine pathway modulation. Case-control studies (NCBI Gene).

Expression Profile

Tissue Expression
Tissue nTPM level
Brain (cerebral cortex) 5.2 Medium
Brain (cerebellum) 3.8 Low
Testis 2.1 Low
Liver 1.0 Not detected
Heart 0.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 4.5 Neuronal model
HEK293 (embryonic kidney) 1.2 Low expression
HepG2 (liver cancer) 0.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs1800497 (Taq1A) SNP (C>T) 0.18 (global) Alters DRD2 expression; associated with addiction and psychiatric disorders.
rs2734849 SNP (G>A) 0.12 May affect ANKK1 kinase activity; linked to bipolar disorder.
rs7118900 SNP (T>C) 0.08 Intronic variant; potential regulatory effect.
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations reported in ANKK1; most variants are regulatory or non-coding.

Gain of Function (GOF)

Not established; the Taq1A polymorphism may indirectly alter DRD2 expression but does not directly affect ANKK1 kinase activity.

Dominant Negative (DN)

No evidence for dominant-negative effects.

Gene Ontology (GO)

• GO:0004672 (protein kinase activity) • GO:0005515 (protein binding)
• GO:0006468 (protein phosphorylation) • GO:0005737 (cytoplasm)
• GO:0005886 (plasma membrane)

Pathways

Dopamine receptor signaling pathway (via DRD2 interaction)
Signal transduction (kinase cascade)

Protein Summary

The ANKK1 protein (UniProt Q8NFH3) contains an N-terminal ankyrin repeat domain and a C-terminal serine/threonine kinase domain. It is predicted to function as a kinase involved in intracellular signaling, potentially modulating dopamine receptor pathways. The protein is expressed in brain regions relevant to reward and cognition. Structural studies are limited, but its proximity to DRD2 and association with psychiatric phenotypes underscore its biological significance.

Related Products

Product name Cat.No. Species Gene ID
ANKK1 Knockout HEK293 Cell Line EDJ-KQ1979 Human 255239 Details Get a Quote
ANKK1 Knockout HeLa Cell Line EDJ-KQ59276 Human 255239 Details Get a Quote
ANKK1 Knockout A-549 Cell Line EDJ-KQ67742 Human 255239 Details Get a Quote
ANKK1 Knockout HCT 116 Cell Line EDJ-KQ76127 Human 255239 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: